Publicação
Pharmacological Therapies in Acne vulgaris
| Resumo: | Acne vulgaris is a chronic disease of the pilosebaceous unit characterized by cutaneous polymorphism, representing one of the most prevalent diseases in adolescence. It can lead to physical sequelae, such as disfiguring scars, and psychological, with a decreased quality of life and psychosocial function. Thus, an effective therapeutic strategy is essential in order to promote its resolution and minimize sequelae. Nowadays, there are several available drugs, but their choice requires biopsychosocial assessment of the patient. Recent studies have shown promising new therapeutic agents, as alternatives to topical retinoids, oral isotretinoin, oral antiandrogens, and antibiotics, which would allow a reduction in antibiotic resistance and a consequent increase in efficacy with a substantial reduction in adverse effects. Increasing security and tolerability of new drugs would improve the current approach of acne treatment. |
|---|---|
| Autores principais: | Esteves Caseiro Mendes de Freitas, Tomás |
| Outros Autores: | Cardoso da Cunha Velho, Glória Maria |
| Assunto: | Acne Vulgaris/drug therapy Administration, Cutaneous Administration, Oral Dermatologic Agents Acne Vulgar/tratamento farmacológico Administração Cutânea Administração Oral Fármacos Dermatológicos |
| Ano: | 2021 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | unknown |
| Instituição associada: | Sociedade Portuguesa de Dermatologia e Venereologia |
| Idioma: | português |
| Origem: | Portuguese Journal of Dermatology |
| Resumo: | Acne vulgaris is a chronic disease of the pilosebaceous unit characterized by cutaneous polymorphism, representing one of the most prevalent diseases in adolescence. It can lead to physical sequelae, such as disfiguring scars, and psychological, with a decreased quality of life and psychosocial function. Thus, an effective therapeutic strategy is essential in order to promote its resolution and minimize sequelae. Nowadays, there are several available drugs, but their choice requires biopsychosocial assessment of the patient. Recent studies have shown promising new therapeutic agents, as alternatives to topical retinoids, oral isotretinoin, oral antiandrogens, and antibiotics, which would allow a reduction in antibiotic resistance and a consequent increase in efficacy with a substantial reduction in adverse effects. Increasing security and tolerability of new drugs would improve the current approach of acne treatment. |
|---|